• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性腹水的恶性生物学行为:生化变量、肿瘤微环境和生长因子之间相互作用的综合综述。

Malignancy of Malignant Ascites: A Comprehensive Review of Interplay between Biochemical Variables, Tumor Microenvironment and Growth Factors.

机构信息

Department of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, 570015, Karnataka, India.

出版信息

Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3413-3420. doi: 10.31557/APJCP.2024.25.10.3413.

DOI:10.31557/APJCP.2024.25.10.3413
PMID:39471006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11711360/
Abstract

Malignant ascites, a buildup of fluid in the abdominal cavity, is a serious consequence of many malignancies. This review aims to comprehend the biochemical makeup of malignant ascites, such as pH, cholesterol, protein, etc., which is crucial to developing therapeutics with better treatment outcomes and hence correlate with corresponding prognostic value. The unique tumour microenvironment exhibited by malignant ascites and the crosstalk between inflammatory cells, cytokines and chemokines, interactions between tumour and non-tumour cell types, activation of vital cell signalling pathways within the TME for VEGF-regulated sustained angiogenesis, cancer progression and metastasis is highlighted. This review addresses the need to develop comprehensive assay platforms to identify various biochemical aspects of ascites, to discover the interactions of the tumour microenvironment and to study VEGF-regulated permeability that can expedite early diagnosis and progression of ascites.

摘要

恶性腹水是许多恶性肿瘤的严重后果,即腹腔内积液的积聚。本综述旨在了解恶性腹水的生化成分,如 pH 值、胆固醇、蛋白质等,这对于开发具有更好治疗效果的治疗方法至关重要,因此与相应的预后价值相关。恶性腹水表现出独特的肿瘤微环境,炎症细胞、细胞因子和趋化因子之间的串扰,肿瘤和非肿瘤细胞类型之间的相互作用,TME 中关键细胞信号通路的激活,以实现 VEGF 调节的持续血管生成、癌症进展和转移,这一点得到了强调。本综述提出需要开发全面的分析平台来识别腹水的各种生化方面,以发现肿瘤微环境的相互作用,并研究 VEGF 调节的通透性,从而加速腹水的早期诊断和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/f594fa4e75c8/APJCP-25-3413-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/6c7557f16b29/APJCP-25-3413-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/66368f23251a/APJCP-25-3413-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/3a351591b0c2/APJCP-25-3413-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/f594fa4e75c8/APJCP-25-3413-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/6c7557f16b29/APJCP-25-3413-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/66368f23251a/APJCP-25-3413-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/3a351591b0c2/APJCP-25-3413-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a653/11711360/f594fa4e75c8/APJCP-25-3413-g004.jpg

相似文献

1
Malignancy of Malignant Ascites: A Comprehensive Review of Interplay between Biochemical Variables, Tumor Microenvironment and Growth Factors.恶性腹水的恶性生物学行为:生化变量、肿瘤微环境和生长因子之间相互作用的综合综述。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3413-3420. doi: 10.31557/APJCP.2024.25.10.3413.
2
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.卵巢癌腹水微环境中生长因子代谢关系的新观点。
Semin Cancer Biol. 2022 Nov;86(Pt 2):709-719. doi: 10.1016/j.semcancer.2022.03.004. Epub 2022 Mar 5.
3
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.腹水调节癌细胞行为,导致卵巢癌肿瘤异质性。
Cancer Sci. 2016 Sep;107(9):1173-8. doi: 10.1111/cas.12987. Epub 2016 Aug 16.
4
Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.腹水细胞外囊泡的蛋白质组学分析描述了卵巢癌中的肿瘤微环境,并预测了患者的生存情况。
J Extracell Vesicles. 2024 Mar;13(3):e12420. doi: 10.1002/jev2.12420.
5
Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.KRAS或c-MYC诱导的卵巢癌相关性腹膜炎中肿瘤微环境的改变
PLoS One. 2016 Aug 2;11(8):e0160330. doi: 10.1371/journal.pone.0160330. eCollection 2016.
6
Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer.计算模型恶性腹水揭示 CCL5-SDC4 相互作用在卵巢癌的免疫微环境。
Mol Carcinog. 2021 May;60(5):297-312. doi: 10.1002/mc.23289. Epub 2021 Mar 15.
7
Immune Tumor Microenvironment in Ovarian Cancer Ascites.卵巢癌腹水的免疫肿瘤微环境。
Int J Mol Sci. 2022 Sep 14;23(18):10692. doi: 10.3390/ijms231810692.
8
Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.间皮细胞通过溶血磷脂酸(LPA)诱导血管内皮生长因子(VEGF)以及恶性腹水中宿主来源VEGF的定量分析。
J Surg Res. 2006 Jan;130(1):94-101. doi: 10.1016/j.jss.2005.08.007. Epub 2005 Sep 19.
9
Role of malignant ascites on human mesothelial cells and their gene expression profiles.恶性腹水对人腹膜间皮细胞及其基因表达谱的作用。
BMC Cancer. 2014 Apr 24;14:288. doi: 10.1186/1471-2407-14-288.
10
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.胆固醇激活恶性腹水癌细胞中的 LXRɑ/β 促进卵巢癌的化疗耐药性。
BMC Cancer. 2018 Dec 10;18(1):1232. doi: 10.1186/s12885-018-5152-5.

引用本文的文献

1
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer.腹膜癌病作为晚期胰腺癌采用纳米脂质体伊立替康与氟尿嘧啶加亚叶酸治疗的有利预后因素。
Ther Adv Med Oncol. 2025 Jun 26;17:17588359251351540. doi: 10.1177/17588359251351540. eCollection 2025.
2
Diagnostic value of vascular endothelial growth factor (VEGF) levels in gastrointestinal cancers with ascites - A cross sectional study.血管内皮生长因子(VEGF)水平在伴有腹水的胃肠道癌中的诊断价值——一项横断面研究。
Turk J Surg. 2025 Feb 27;41(1):78-84. doi: 10.47717/turkjsurg.2025.6592.

本文引用的文献

1
Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology.溶血磷脂酸(LPA)受体介导的信号通路在癌细胞生物学中的作用。
J Bioenerg Biomembr. 2024 Aug;56(4):475-482. doi: 10.1007/s10863-024-10028-9. Epub 2024 Jun 18.
2
Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.腹水细胞外囊泡的蛋白质组学分析描述了卵巢癌中的肿瘤微环境,并预测了患者的生存情况。
J Extracell Vesicles. 2024 Mar;13(3):e12420. doi: 10.1002/jev2.12420.
3
Advances in the treatment of malignant ascites in China.
中国恶性腹水治疗的进展。
Support Care Cancer. 2024 Jan 11;32(2):97. doi: 10.1007/s00520-023-08299-w.
4
Differential diagnosis of ascites: etiologies, ascitic fluid analysis, diagnostic algorithm.腹水的鉴别诊断:病因、腹水分析、诊断算法
Clin Chem Lab Med. 2023 Dec 20;62(7):1266-1276. doi: 10.1515/cclm-2023-1112. Print 2024 Jun 25.
5
Tumor microenvironment in ovarian cancer peritoneal metastasis.卵巢癌腹膜转移中的肿瘤微环境
Cancer Cell Int. 2023 Jan 25;23(1):11. doi: 10.1186/s12935-023-02854-5.
6
Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer.单细胞测序恶性腹水揭示上皮性卵巢癌进展过程中肿瘤微环境的转录组重构。
Genes (Basel). 2022 Dec 2;13(12):2276. doi: 10.3390/genes13122276.
7
Acidic ascites inhibits ovarian cancer cell proliferation and correlates with the metabolomic, lipidomic and inflammatory phenotype of human patients.酸性腹水抑制卵巢癌细胞增殖,并与人类患者的代谢组学、脂质组学和炎症表型相关。
J Transl Med. 2022 Dec 12;20(1):581. doi: 10.1186/s12967-022-03763-3.
8
Friend and foe: the regulation network of ascites components in ovarian cancer progression.友与敌:卵巢癌进展过程中腹水成分的调控网络
J Cell Commun Signal. 2023 Sep;17(3):391-407. doi: 10.1007/s12079-022-00698-8. Epub 2022 Oct 13.
9
Immune Tumor Microenvironment in Ovarian Cancer Ascites.卵巢癌腹水的免疫肿瘤微环境。
Int J Mol Sci. 2022 Sep 14;23(18):10692. doi: 10.3390/ijms231810692.
10
Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.卵巢癌球体形成和腹膜转移:基质和免疫成分的作用。
Int J Mol Sci. 2022 Jun 1;23(11):6215. doi: 10.3390/ijms23116215.